Get started

Techieindustrader

Metal Stocks to rally next Keep an eye on Metal stocks the Index brekout bound to happen . JSW steel is breaking out with volumes : NIFTY target 17500 , JSW targets as shown . ==================================================================================== Fundamental : Revenue 20.3% NetProfit 39.3% OperatingProfit 27.2% Strong Annual EPS Growth Effectively using its capital to generate profit - RoCE improving in last 2 years Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year Efficient in managing Assets to generate Profits - ROA improving since last 2 year Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years Annual Net Profits improving for last 2 years Book Value per share Improving for last 2 years FII / FPI or Institutions increasing their shareholding ======================================================================================= ## F&O data suggests Short Covering today ## Positive Breakout Second Resistance ( LTP > R2) ## Stock with Low PE (PE < = 10) ## RSI indicating price strength
NSE:JSWSTEELLong
by TechieindusTrader
L&T targets as shown Refer figure for targets : ====================================== Good quarterly growth in the recent results Book Value per share Improving for last 2 years Strong Momentum: Price above short, medium and long term moving averages Outperformer - Larsen & Toubro up by 16.1% v/s NIFTY 50 up by 6.81% in last 1 month Bullish Momentum - Above Short, Medium and Long Term Moving Averages Mutual Funds have increased holdings from 17.67% to 18.25% in Jun 2022 qtr. 13.34% away from 52 week high =======================================
NSE:LTLong
by TechieindusTrader
Aarti Drugs Target 485-520Market Expectation At ₹432.55, the market expects Aarti Drugs to grow profits by 12.4% per year If it grows profits by 15.4% per year, the stock should be priced at ₹488.23. current share price is 11% Undervalued Past Performance Last year, profits declined by -21.6% Profits over past 5 years grew by 26.3% per year Forecast Range from 3 Analysts To achieve the most bearish analyst forecast (₹460.00), profits would need to grow by 13.9% per year To achieve the most bullish analyst forecast (₹485.00), profits would need to grow by 15.2% per year Industry & Market Trend Companies in the Pharmaceuticals industry grew profits by 4.4% last year Companies in the India market grew profits by 30.8% last year Company has delivered good profit growth of 21.37% CAGR over last 5 years Company has a good return on equity (ROE) track record: 3 Years ROE 26.13% Good Risk to Reward Show
NSE:AARTIDRUGSLong
by TechieindusTrader